This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klingenheben, T. Articles by Hohnloser, S. H. Search for Related Content PubMed PubMed Citation Articles by Klingenheben, T. Articles by Hohnloser, S. H.

Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans

Results of a prospective, double-blind, randomized study

^a Department of Medicine, Division of Cardiology, J.W. Goethe University, Frankfurt, Germany

View larger version (15K): [in a new window]   Figure 1 Study protocol. EP = electrophysiologic; TWA = T-wave alternans; VF = ventricular fibrillation; VT = ventricular tachycardia.

View larger version (60K): [in a new window]   Figure 2 Reproducibility of T-wave alternans (TWA) analysis. (A) TWA amplitudes (alternan voltage [Valt]) at two repetitive drug-free baseline measurements in 12 patients. (B) Representative TWA recordings in a patient with stable TWA amplitutes (Valt) at repetitive drug-free measurements (NS = not significant). BPM = beats per minute; HR = heart rate.

View larger version (57K): [in a new window]   Figure 3 (A) Changes in heart rate following drug administration. (B) Changes in ventricular effective refractory periods following drug administration. (C) Changes in T-wave alternans (TWA) amplitude following drug administration (Valt) in patients with d,l-sotalol (dark bars) and metoprolol (gray bars). (D) Representative example of a patient with a significant decrease in Valt in nearly all electrocardiographic leads following administration of d,l-sotalol (left: before drug administration; right: after drug administration). BPM = beats per minute; HR = heart rate.